Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone implant in non-infectious intermediate or posterior uveitis
NCT00333814Phase 3Completed
- Sponsor
- Allergan
- Start
- May 2006
- Primary completion
- Dec 2008
- Modality
- Orthosteric Ligands
- Countries
- 18
01
Overview
Phase 3, randomised, double-blind trial of dexamethasone in intermediate uveitis (IU) and posterior uveitis (3 arms), sponsored by Allergan. Primary endpoint: Percentage of Patients With Vitreous Haze (Ocular Inflammation) Score of Zero at Week 8. Started May 2006; status: completed.
02
Drugs
dexamethasone
03
Conditions
intermediate uveitis (IU)posterior uveitis
Beyond the preview
Go deeper on NCT00333814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00333814.